Literature DB >> 25877323

[Standards for the diagnosis and treatment of primary lung cancer (2015 version) in China].

Xiuyi Zhi, Yuankai Shi1, Jinming Yu.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25877323

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN： 0253-3766


× No keyword cloud information.
  27 in total

Review 1.  China experts consensus on icotinib for non-small cell lung cancer treatment (2015 version).

Authors:  Yuankai Shi; Yan Sun; Cuimin Ding; Ziping Wang; Changli Wang; Zheng Wang; Chong Bai; Chunxue Bai; Jifeng Feng; Xiaoqing Liu; Fang Li; Yue Yang; Yongqian Shu; Milu Wu; Jianxing He; Yiping Zhang; Shucai Zhang; Gongyan Chen; Honghe Luo; Rongcheng Luo; Caicun Zhou; Yanbin Zhou; Qingsong Pang; Hong Zhao; Qiong Zhao; Aiqin Gu; Yang Ling; Cheng Huang; Baohui Han; Shunchang Jiao; Hong Jiao
Journal:  Ann Transl Med       Date:  2015-10

Review 2.  China experts consensus on icotinib for non-small cell lung cancer treatment (2015 version).

Authors:  Yuankai Shi; Yan Sun; Cuimin Ding; Ziping Wang; Changli Wang; Zheng Wang; Chong Bai; Chunxue Bai; Jifeng Feng; Xiaoqing Liu; Fang Li; Yue Yang; Yongqian Shu; Milu Wu; Jianxing He; Yiping Zhang; Shucai Zhang; Gongyan Chen; Honghe Luo; Rongcheng Luo; Caicun Zhou; Yanbin Zhou; Qingsong Pang; Hong Zhao; Qiong Zhao; Aiqin Gu; Yang Ling; Cheng Huang; Baohui Han; Shunchang Jiao; Hong Jiao
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

3.  Serum microRNAs improving the diagnostic accuracy in lung cancer presenting with pulmonary nodules.

Authors:  Yayi He; Shengxiang Ren; Yan Wang; Xuefei Li; Caicun Zhou; Fred R Hirsch
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

4.  Responses to crizotinib in patients with ALK-positive lung adenocarcinoma who tested immunohistochemistry (IHC)-positive and fluorescence in situ hybridization (FISH)-negative.

Authors:  Di Ma; Zheng Wang; Lin Yang; Xinlin Mu; Yan Wang; Xinming Zhao; Junling Li; Dongmei Lin
Journal:  Oncotarget       Date:  2016-09-27

5.  Cost-effectiveness of gefitinib, icotinib, and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China.

Authors:  Shun Lu; Ming Ye; Lieming Ding; Fenlai Tan; Jie Fu; Bin Wu
Journal:  Oncotarget       Date:  2017-02-07

6.  [Clinicopathologic Characteristics of the Patients in the Elderly Lung Carcinoma].

Authors:  Jie Chen; Xuezhi Hao; Fang Cheng; Tongtong Zhang; Puyuan Xing; Junling Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-10-20

7.  Radiological and pathological analysis of LDCT screen detected and surgically resected sub-centimetre lung nodules in 44 asymptomatic patients.

Authors:  Xing Hu; Jiangmin Zhao; Haishan Qian; Guangyan Du; Margaret Kelly; Hua Yang
Journal:  Eur J Radiol Open       Date:  2016-08-16

Review 8.  [Application of Interventional Bronchoscopy in Pulmonary Peripheral Lesions].

Authors:  Hui Wang; Linian Huang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-08-20

9.  [China Experts Consensus on Icotinib for Non-small Cell Lung Cancer Treatment
(2016 version)].

Authors:  Yuankai Shi; Yan Sun; Cuimin Ding; Ziping Wang; Changli Wang; Chong Bai; Chunxue Bai; Jifeng Feng; Xiaoqing Liu; Fang Li; Yue Yang; Yongqian Shu; Milu Wu; Jianxing He; Yiping Zhang; Shucai Zhang; Gongyan Chen; Honghe Luo; Rongcheng Luo; Caicun Zhou; Qingsong Pang; Xingsheng Hu; Hong Zhao; Qiong Zhao; Aiqin Gu; Yang Ling; Cheng Huang; Baohui Han; Shunchang Jiao; Hong Jian
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-07-20

10.  Deep Learning on MRI Images for Diagnosis of Lung Cancer Spinal Bone Metastasis.

Authors:  Xiaojie Fan; Xiaoyu Zhang; Zibo Zhang; Yifang Jiang
Journal:  Contrast Media Mol Imaging       Date:  2021-07-14       Impact factor: 3.161
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.